Loading chat...
CT HB06062
Bill
Status
1/22/2025
Primary Sponsor
General Law Committee
Click for details
AI Summary
-
Prohibits any person engaged in trade or commerce in Connecticut from directly advertising legend (prescription) drugs to consumers physically present in the state, effective October 1, 2025
-
Exempts pharmaceutical manufacturers registered with the Department of Consumer Protection as marketing firms, and their representatives, from the advertising ban when promoting drugs to prescribing practitioners
-
Classifies violations as unfair or deceptive trade practices under Connecticut General Statutes section 42-110b
-
Authorizes the Commissioner of Consumer Protection to adopt regulations implementing the new restrictions
Legislative Description
An Act Prohibiting Direct-to-consumer Prescription Drug Advertisements.
Last Action
Referred by House to Committee on Appropriations
4/29/2025